Dossier · FA · Dormant
FA · First Advantage Corporation · Stock research
Last analysed ·
Current thesis
Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first time. A second leg on a labour-cyclical base that is still decelerating; the next test is payrolls, not the company.
Invalidation trigger
A weekly close below $22 returns price inside the pre-print July range ($19.91–$22.49) and negates the Aug 6 earnings breakout; base revenue growth printing under 6.7% or a trimmed FY revenue range at the Q3 report would confirm the labour-cycle drag reaching the volume base.
Thesis status
Open commitment scored if the trigger above fires How this is scored →Latest analysis and events for FA —
As of 2026-08-09, orbyd's latest analysis for First Advantage Corporation (FA): Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first time. A second leg on a labour-cyclical base that is still decelerating; the next test is payrolls, not the company.
Invalidation trigger: A weekly close below $22 returns price inside the pre-print July range ($19.91–$22.49) and negates the Aug 6 earnings breakout; base revenue growth printing under 6.7% or a trimmed FY revenue range at the Q3 report would confirm the labour-cycle drag reaching the volume base.
Note: this dossier is a refresh of existing coverage (first covered 2026-07-15). The Aug 6 print has since resolved the event the prior note was framed around.
FA — First Advantage Corporation
Current Thesis
The Aug 6 print was the binary in the previous read, and it resolved upward. Q2 2026 revenue came in at $448.8M, +14.9% YoY, against a $415.0M consensus; adjusted diluted EPS was $0.35 against $0.28. Management then raised FY2026 guidance on all three lines — the first raise of this cycle after reaffirming at Q1 on May 8. The strongest bear point in the prior frame, that price traded above every published sell-side target, inverted within 24 hours: Needham upgraded to Buy with a $28 target on Aug 6, and RBC lifted its target to $24 on Aug 7, four sessions after taking it to $21 on Aug 3.
The narrative leg on offer is a second one: growth accelerating from +8.6% in Q1 to +14.9% in Q2 on a like-for-like post-Sterling base (the $2.2B Sterling deal closed 2024-10-31, so the year-ago quarter already contained it), free cash going into debt prepayment and buyback, and a background-screening volume base that grew 6.7% organically despite a visibly cooling US labour market. Last close $24.01 (Aug 7), 0.5% under the $24.12 52-week high, RSI(14) 57.3, three-month return +50.4%.
Bullish and bearish views on First Advantage Corporation
The model's bull view on First Advantage Corporation (FA), in brief: Q2 2026 (reported 2026-08-06): revenue $448.8M, +14.9% YoY, vs $415.0M consensus — an acceleration from the +8.6% printed at Q1 on 2026-05-08. The bear view: The re-rate is largely spent. Shares sit 0.5% below the $24.12 52-week high after a +50.4% three-month run and a near-triple from the $8.82 52-week low. Headroom is one analyst wide. The most recent maintained rating — RBC's Aug 7 note — carries a $24 target at a Sector Perform… Both cases follow in full.
Bull Case
- Q2 2026 (reported 2026-08-06): revenue $448.8M, +14.9% YoY, vs $415.0M consensus — an acceleration from the +8.6% printed at Q1 on 2026-05-08.
- Base revenue — existing customers' screening volumes — grew 6.7% in Q2; upsell, cross-sell and new-logo revenue grew 12.5%, with 20 enterprise bookings closed in the quarter. The organic line expanded while US payroll growth was slowing.
- Profitability: adjusted EBITDA $128.5M at a 28.6% margin, up 13% YoY; GAAP net income $16.9M ($0.10 diluted); adjusted diluted EPS $0.35 vs $0.28 consensus.
- FY2026 guidance raised across the board on 2026-08-06: revenue to $1.67–1.71B from $1.625–1.700B, adjusted EBITDA to $472–486M from $460–485M, adjusted diluted EPS to $1.23–1.29 from $1.15–1.25 against a $1.22 consensus.
- Deleveraging executed with cash: a $25M voluntary debt prepayment on May 6 and a further $45M on Aug 4, against $2,033.8M long-term debt and $237.9M cash at Jun 30 2026.
- Capital returned into the advance rather than shares issued into it: $18.7M repurchased in Q2 and $38.2M year-to-date through Jul 31, roughly 1.9% of shares outstanding.
- The published target frame reset above spot: Needham Buy/$28 (Aug 6) and RBC Sector Perform/$24 (Aug 7) versus an $18–20 top end as recently as May 8.
Bear Case
- The re-rate is largely spent. Shares sit 0.5% below the $24.12 52-week high after a +50.4% three-month run and a near-triple from the $8.82 52-week low.
- Headroom is one analyst wide. The most recent maintained rating — RBC's Aug 7 note — carries a $24 target at a Sector Perform, level with the $24.01 close. Needham's $28 is the only target offering room.
- The guidance raise is small next to the quarter. Q2 revenue printed $448.8M against a $415.0M consensus, yet the FY revenue top end moved only from $1.700B to $1.710B — implied second-half revenue was barely marked up.
- Base revenue growth of 6.7% is the number levered to hiring, and hiring is decelerating: US payrolls +57k in June against +129k in May. Screening volumes track that series with a lag.
- Leverage remains the structural constraint: $2,033.8M long-term debt at Jun 30 2026. A volume air-pocket slows the deleveraging arithmetic the equity multiple has been discounting.
- Nothing company-specific is scheduled inside the next 30 days, so between now and the Q3 print the shares trade on macro labour data and on flows.
Setup & Price Structure
- Last close $24.01 (2026-08-07); 52-week range $8.82–$24.12; three-month return +50.4%; RSI(14) 57.3.
- The Aug 6 result carried price out of the July consolidation. The week of Jul 14 ranged $19.91–$22.49 and the prior 52-week high was $22.78; the $22.5–22.8 area is now the first structural shelf beneath the market, with $19.9–20.0 the deeper one.
- RSI(14) at 57.3 while price sits at a 52-week high is worth naming: the index is not stretched, which is consistent with a range that consolidated through July and then broke rather than a vertical chase.
- Life-cycle: ACCELERATING, dated 2026-08-06 — new fundamental information (first FY raise of the cycle, growth 8.6% → 14.9%), a rating upgrade, and two target raises inside five sessions (RBC $21 on Aug 3 → $24 on Aug 7). The label is early-stage and fragile: with only one target above spot, the sell-side has re-rated to price rather than ahead of it, and a stall here would move the read toward SATURATED quickly.
- Crowding and positioning observables, stated as observables: sell-side revisions cluster inside one week (Aug 3, Aug 6, Aug 7); price is 0.5% from the 52-week high; there is no earnings date inside 30 days, so the next event risk is macro; the recent filing feed shows no insider sale prints for this name; and the company is buying stock back ($38.2M YTD through Jul 31), which is the opposite of issuing equity into strength.
- What is absent: any post-print base. The breakout is three sessions old as of the Aug 7 close, and there is no consolidation yet to define support other than the pre-print range.
Catalyst Calendar (next 30 days)
- ~2026-09-04 (est.) — US August employment report (BLS, first Friday). Direct read-through to the base-revenue line; the June +57k versus May +129k trajectory is the macro condition the 6.7% base growth has to survive.
- No company-specific event is scheduled inside the 30-day window. The Q2 10-Q was filed alongside the Aug 6 release; the debt prepayment disclosed for Aug 4 has already occurred.
- ~2026-11-05 (est.) — Q3 2026 results, outside the window. That print is where the raised $1.67–1.71B FY range is either confirmed or walked back.
What Would Change Our Mind
The structure to watch is the Aug 6 gap. If price fills back into the pre-print July range, the raise stopped being priced and the second leg failed at the first attempt — specifically, a weekly close below $22 returns the shares inside the $19.91–$22.49 July range and negates the earnings breakout.
On fundamentals, three observables would break the frame independently of price. Base revenue growth printing below 6.7% at the Q3 report would show the labour cycle finally reaching the volume base. A trimmed or merely reaffirmed FY revenue range off $1.67–1.71B at Q3, after a Q2 beat of that size, would say the second-half raise was never real. And a run of payroll prints below June's +57k would remove the macro support for the organic line before the company reports.
On positioning, if no additional target moves above $24.01 by the Q3 print while price holds near the high, the ACCELERATING label is wrong and the name is late-cycle with a thin incremental bid.
Correlation Notes
- The dominant factor is US hiring volume, not enterprise-software spend. The monthly BLS payroll release is the highest-frequency input to revenue; the read-across is to staffing and payroll-services activity rather than to software multiples.
- The company's own framing — an "AI-driven proprietary technology platform" and Digital Identity products, per the Aug 6 release — means the shares occasionally move with the AI-software cohort on sentiment days without a fundamental link to that cohort's capex cycle. Prior coverage flagged the "ai-enterprise-software" tag as loose for exactly this reason; the tagging here is now labour-cyclical.
- Rate and credit sensitivity is real: $2,033.8M of long-term debt at Jun 30 2026 makes the equity a levered claim on screening volumes, with the $25M (May 6) and $45M (Aug 4) voluntary prepayments as the offset.
- Sponsor structure: Silver Lake affiliates have been the anchor holder since the 2020 take-private and the 2021 IPO, so any registered secondary is a supply event independent of operating results.
Notes
- Revenue is levered to US hiring volume, not AI capex; the monthly BLS payroll release is the highest-frequency input to the base-revenue line.
- Long-term debt was $2,033.8M against $237.9M cash at 2026-06-30; the equity is a levered claim on screening volumes.
- FY2026 guidance is calendar-year and was raised 2026-08-06: revenue $1.67-1.71B, adj EBITDA $472-486M, adj diluted EPS $1.23-1.29.
- Sterling ($2.2B) closed 2024-10-31, so YoY comparisons from Q1 2026 onward are against a combined base rather than a deal-inflated one.
- Silver Lake affiliates have been the anchor holder since the 2020 take-private and 2021 IPO; a registered secondary would be a supply event.
Related · shared themes
IRDM
Iridium Communications Inc
Deal-arb discount narrowed to 7.5%: RKLB closed $82.83 on 2026-08-07, $15.33 inside the collar's flat band, so the package still marks $54.00 against IRDM's $49.93. Forty days post-announcement there is still no Form S-4, no FCC docket and no disclosed HSR expiry. Rocket Lab's 2026-08-10 print is the next dated input.
TXG
10x Genomics, Inc.
Atera's order book turned the name: the 2026-08-06 beat-and-raise first sold to $45.60, then reversed to a record $52.03 close on 2026-08-07 (+14.10%, 5.43M shares) with the 16-analyst average target moving $41.54→$46.31 in two sessions. Demand is proven; factory capacity gates 2026 revenue and the next hard number is the ~2026-11-05 Q3 print.
XPO
XPO, Inc.
Beat-and-raise LTL margin story the tape only half pays for: after Q2 adjusted OR 79.9% and an at-least-200bps full-year guide, price lost the $199–$201 shelf on 2026-08-03 at $197.01 and reclaimed it 2026-08-07 at $202.58 with no company news attached. July Cass (~08-13) and ATA (~08-18) decide whether the above-6% July tonnage is a demand turn or share transfer.
BFLY
Butterfly Network, Inc.
Butterfly Embedded chip-licensing story got marquee validation — Midjourney's up-to-$74M/5yr full-body scanner on 40 Ultrasound-on-Chip modules (2026-06-18) plus 2nd partner Aleph Neuro (2026-06-25). Fundamentals still accelerating, but the June double has stalled and news thinned; a binary Q2 print (~early Aug) is now the next input and the easy momentum leg is spent.
See also · stocks to watch